{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:20:43Z","timestamp":1793283643531,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00249120"],"award-info":[{"award-number":["RS-2023-00249120"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI23C1506"],"award-info":[{"award-number":["HI23C1506"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Research Program of the Korea Medical Institute."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The long-term association between mRNA-based coronavirus disease 2019 (COVID-19) vaccination and the development of autoimmune connective tissue diseases (AI-CTDs) remains unclear. In this nationwide, population-based cohort study involving 9,258,803 individuals, we aim to determine whether the incidence of AI-CTDs is associated with mRNA vaccination. The study spans over 1 year of observation and further analyses the risk of AI-CTDs by stratifying demographics and vaccination profiles and treating booster vaccination as time-varying covariate. We report that the risk of developing most AI-CTDs did not increase following mRNA vaccination, except for systemic lupus erythematosus with a 1.16-fold risk in vaccinated individuals relative to controls. Comparable results were reported in the stratified analyses for age, sex, mRNA vaccine type, and prior history of non-mRNA vaccination. However, a booster vaccination was associated with an increased risk of some AI-CTDs including alopecia areata, psoriasis, and rheumatoid arthritis. Overall, we conclude that mRNA-based vaccinations are not associated with an increased risk of most AI-CTDs, although further research is needed regarding its potential association with certain conditions.<\/jats:p>","DOI":"10.1038\/s41467-024-50656-8","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T20:02:18Z","timestamp":1721678538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-1513","authenticated-orcid":false,"given":"Seung-Won","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5805-826X","authenticated-orcid":false,"given":"Jae Joon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5963-4444","authenticated-orcid":false,"given":"You Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-9709","authenticated-orcid":false,"given":"Sung Jay","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6458-9449","authenticated-orcid":false,"given":"Solam","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"50656_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41109-9","volume":"14","author":"D Mongin","year":"2023","unstructured":"Mongin, D. et al. Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection. Nat. Commun. 14, 5452 (2023).","journal-title":"Nat. Commun."},{"key":"50656_CR2","doi-asserted-by":"publisher","first-page":"e1004107","DOI":"10.1371\/journal.pmed.1004107","volume":"19","author":"I Bergeri","year":"2022","unstructured":"Bergeri, I. et al. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. PLoS Med. 19, e1004107 (2022).","journal-title":"PLoS Med."},{"key":"50656_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250022","volume":"53","author":"NM Provine","year":"2023","unstructured":"Provine, N. M. & Klenerman, P. Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity. Eur. J. Immunol. 53, e2250022 (2023).","journal-title":"Eur. J. Immunol."},{"key":"50656_CR4","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","volume":"384","author":"N Dagan","year":"2021","unstructured":"Dagan, N. et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N. Engl. J. Med. 384, 1412\u20131423 (2021).","journal-title":"N. Engl. J. Med."},{"key":"50656_CR5","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0140-6736(21)00790-X","volume":"397","author":"VJ Hall","year":"2021","unstructured":"Hall, V. J. et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet 397, 1725\u20131735 (2021).","journal-title":"Lancet"},{"key":"50656_CR6","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.vaccine.2023.03.054","volume":"41","author":"G Santi Laurini","year":"2023","unstructured":"Santi Laurini, G., Montanaro, N., Broccoli, M., Bonaldo, G. & Motola, D. Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database. Vaccine 41, 2879\u20132886 (2023).","journal-title":"Vaccine"},{"key":"50656_CR7","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/vaccines11061118","volume":"11","author":"W Xu","year":"2023","unstructured":"Xu, W. et al. Real-world safety of COVID-19 mRNA vaccines: A systematic review and meta-analysis. Vaccines 11, 1118 (2023).","journal-title":"Vaccines"},{"key":"50656_CR8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jama.2021.15072","volume":"326","author":"NP Klein","year":"2021","unstructured":"Klein, N. P. et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA 326, 1390\u20131399 (2021).","journal-title":"JAMA"},{"key":"50656_CR9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda, N. et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N. Engl. J. Med. 385, 1078\u20131090 (2021).","journal-title":"N. Engl. J. Med."},{"key":"50656_CR10","doi-asserted-by":"publisher","first-page":"e065687","DOI":"10.1136\/bmjopen-2022-065687","volume":"13","author":"A Alami","year":"2023","unstructured":"Alami, A. et al. Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis. BMJ Open 13, e065687 (2023).","journal-title":"BMJ Open"},{"key":"50656_CR11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jhep.2021.06.004","volume":"75","author":"MC Londo\u00f1o","year":"2021","unstructured":"Londo\u00f1o, M. C., Gratac\u00f3s-Gin\u00e8s, J. & S\u00e1ez-Pe\u00f1ataro, J. Another case of autoimmune hepatitis after SARS-CoV-2 vaccination-still casualty? J. Hepatol. 75, 1248\u20131249 (2021).","journal-title":"J. Hepatol."},{"key":"50656_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000523962","volume":"53","author":"R Fenoglio","year":"2022","unstructured":"Fenoglio, R. et al. New onset biopsy-proven nephropathies after COVID vaccination. Am. J. Nephrol. 53, 325\u2013330 (2022).","journal-title":"Am. J. Nephrol."},{"key":"50656_CR13","unstructured":"Korea Disease Control and Prevention Agency. COVID-19 vaccination status. https:\/\/www.kdca.go.kr\/board\/board.esmid=a20501010000&bid=0015&list_no=720988&cg_code=&act=view&nPage=1&newsField=202210 (2022)."},{"key":"50656_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\u2013838 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"50656_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.autrev.2017.05.012","volume":"16","author":"B Wang","year":"2017","unstructured":"Wang, B., Shao, X., Wang, D., Xu, D. & Zhang, J. A. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis. Autoimmun. Rev. 16, 756\u2013765 (2017).","journal-title":"Autoimmun. Rev."},{"key":"50656_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jaad.2021.04.061","volume":"86","author":"M Kasperkiewicz","year":"2022","unstructured":"Kasperkiewicz, M. & Woodley, D. T. Association between vaccination and autoimmune bullous diseases: A systematic review. J. Am. Acad. Dermatol. 86, 1160\u20131164 (2022).","journal-title":"J. Am. Acad. Dermatol."},{"key":"50656_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.7326\/M23-1831","volume":"177","author":"MS Kim","year":"2024","unstructured":"Kim, M. S. et al. Long-term autoimmune inflammatory rheumatic outcomes of COVID-19: A binational cohort study. Ann. Intern. Med. 177, 291\u2013302 (2024).","journal-title":"Ann. Intern. Med."},{"key":"50656_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jaad.2023.05.017","volume":"89","author":"HJ Ju","year":"2023","unstructured":"Ju, H. J. et al. Risk of autoimmune skin and connective tissue disorders after mRNA-based COVID-19 vaccination. J. Am. Acad. Dermatol. 89, 685\u2013693 (2023).","journal-title":"J. Am. Acad. Dermatol."},{"key":"50656_CR19","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00296-022-05203-3","volume":"42","author":"I Sagy","year":"2022","unstructured":"Sagy, I. et al. New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review. Rheumatol. Int. 42, 2261\u20132266 (2022).","journal-title":"Rheumatol. Int."},{"key":"50656_CR20","doi-asserted-by":"publisher","first-page":"1259879","DOI":"10.3389\/fimmu.2023.1259879","volume":"14","author":"M Heil","year":"2024","unstructured":"Heil, M. Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies. Front. Immunol. 14, 1259879 (2024).","journal-title":"Front. Immunol."},{"key":"50656_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fimmu.2019.00502","volume":"10","author":"B Duvvuri","year":"2019","unstructured":"Duvvuri, B. & Lood, C. Cell-Free DNA as a biomarker in autoimmune rheumatic diseases. Front. Immunol. 10, 502 (2019).","journal-title":"Front. Immunol."},{"key":"50656_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.medj.2022.05.005","volume":"3","author":"I Fox-Fisher","year":"2022","unstructured":"Fox-Fisher, I. et al. B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodies. Med. 3, 468\u2013480.e5 (2022).","journal-title":"Med"},{"key":"50656_CR23","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"50656_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"50656_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jaci.2021.06.026","volume":"148","author":"MM Tomayko","year":"2021","unstructured":"Tomayko, M. M. et al. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J. Allergy Clin. Immunol. 148, 750\u2013751 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"50656_CR26","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S2665-9913(21)00108-9","volume":"3","author":"KA Terracina","year":"2021","unstructured":"Terracina, K. A. & Tan, F. K. Flare of rheumatoid arthritis after COVID-19 vaccination. Lancet Rheumatol. 3, e469\u2013e470 (2021).","journal-title":"Lancet Rheumatol."},{"key":"50656_CR27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1136\/annrheumdis-2021-220732","volume":"80","author":"M Barbhaiya","year":"2021","unstructured":"Barbhaiya, M. et al. Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Ann. Rheum. Dis. 80, 1352\u20131354 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"50656_CR28","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.mayocp.2022.06.001","volume":"97","author":"N Abe","year":"2022","unstructured":"Abe, N., Bohgaki, M. & Kasahara, H. SARS-CoV-2 mRNA Vaccination-induced autoimmune polyarthritis-like rheumatoid arthritis. Mayo Clin. Proc. 97, 1574\u20131575 (2022).","journal-title":"Mayo Clin. Proc."},{"key":"50656_CR29","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/S2665-9913(22)00330-7","volume":"5","author":"KH Bj\u00f8rlykke","year":"2023","unstructured":"Bj\u00f8rlykke, K. H. et al. Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study. Lancet Rheumatol. 5, e36\u2013e46 (2023).","journal-title":"Lancet Rheumatol."},{"key":"50656_CR30","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2665-9913(23)00272-2","volume":"6","author":"JS Hanberg","year":"2024","unstructured":"Hanberg, J. S. et al. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial. Lancet Rheumatol. 6, e21\u2013e30 (2024).","journal-title":"Lancet Rheumatol."},{"key":"50656_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10038-005-0246-8","volume":"50","author":"M Mori","year":"2005","unstructured":"Mori, M., Yamada, R., Kobayashi, K., Kawaida, R. & Yamamoto, K. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J. Hum. Genet. 50, 264\u2013266 (2005).","journal-title":"J. Hum. Genet."},{"key":"50656_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","volume":"19","author":"DS Pisetsky","year":"2023","unstructured":"Pisetsky, D. S. Pathogenesis of autoimmune disease. Nat. Rev. Nephrol. 19, 509\u2013524 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"50656_CR33","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s41591-022-01750-1","volume":"28","author":"C Arsenault","year":"2022","unstructured":"Arsenault, C. et al. COVID-19 and resilience of healthcare systems in ten countries. Nat. Med. 28, 1314\u20131324 (2022).","journal-title":"Nat. Med."},{"key":"50656_CR34","doi-asserted-by":"publisher","first-page":"e045343","DOI":"10.1136\/bmjopen-2020-045343","volume":"11","author":"R Moynihan","year":"2021","unstructured":"Moynihan, R. et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open 11, e045343 (2021).","journal-title":"BMJ Open"},{"key":"50656_CR35","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","volume":"40","author":"E Rohner","year":"2022","unstructured":"Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586\u20131600 (2022).","journal-title":"Nat. Biotechnol."},{"key":"50656_CR36","first-page":"799","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong, S. et al. Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int. J. Epidemiol. 46, 799\u2013800 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"50656_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583\u2013590 (2022).","journal-title":"Nat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50656-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50656-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50656-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T23:48:16Z","timestamp":1721951296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50656-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50656"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50656-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4254839\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6181"}}